These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10625111)

  • 21. In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine.
    Chang WH; Augustin B; Lane HY; ZumBrunnen T; Liu HC; Kazmi Y; Jann MW
    Psychopharmacology (Berl); 1999 Jul; 145(1):91-8. PubMed ID: 10445377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
    Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
    J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
    Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
    Kootstra-Ros JE; Smallegoor W; van der Weide J
    Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service.
    Jerling M; Lindström L; Bondesson U; Bertilsson L
    Ther Drug Monit; 1994 Aug; 16(4):368-74. PubMed ID: 7974626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.
    Spina E; Avenoso A; Facciolà G; Fabrazzo M; Monteleone P; Maj M; Perucca E; Caputi AP
    Int Clin Psychopharmacol; 1998 May; 13(3):141-5. PubMed ID: 9690983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
    Aravagiri M; Marder SR
    J Pharm Biomed Anal; 2001 Sep; 26(2):301-11. PubMed ID: 11470207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
    Dettling M; Sachse C; Brockmöller J; Schley J; Müller-Oerlinghausen B; Pickersgill I; Rolfs A; Schaub RT; Schmider J
    Psychopharmacology (Berl); 2000 Sep; 152(1):80-6. PubMed ID: 11041319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
    Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
    Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma.
    Freeman DJ; Li MC; Oyewumi K
    Ther Drug Monit; 1996 Dec; 18(6):688-92. PubMed ID: 8946666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.
    Ozdemir V; Kalow W; Okey AB; Lam MS; Albers LJ; Reist C; Fourie J; Posner P; Collins EJ; Roy R
    J Clin Psychopharmacol; 2001 Dec; 21(6):603-7. PubMed ID: 11763009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
    Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
    Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
    Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
    Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
    Iverson S; Zahid N; Uetrecht JP
    Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method.
    Kamil Gharab KM; Onmaz DE; Abusoglu S; Aydin M; Sivrikaya A; Tok O; Abusoglu G; Unlu A
    J Pharm Biomed Anal; 2020 Feb; 180():113056. PubMed ID: 31887669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
    Carrillo JA; Herraiz AG; Ramos SI; Benítez J
    J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
    Iglesias García C; Iglesias Alonso A; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(4):192-196. PubMed ID: 28844295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
    Ming DS; Heathcote J
    J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients.
    Cirimele V; Kintz P; Gosselin O; Ludes B
    Forensic Sci Int; 2000 Jan; 107(1-3):289-300. PubMed ID: 10689581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
    Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
    J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.